- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Search
- Contact Webmaster
- Website policies
- Disability services
Endocrinology’s 2017 Fellows…
Endocrinology Fellowship Program Congratulations to Divya Akshintala, Radhika Chugh and Nada Fanous for matching in the 2017-2019 Endocrinology Fellowship program at the University of Florida. It is an honor to have these talented individuals […]
UF clinical trial tests efficacy of drug to treat a rare, and often deadly childhood disease
GAINESVILLE, Fla. — A University of Florida researcher with a $2 million federal grant is launching the first Phase III clinical trial for treatment of a congenital disease of the […]
Congratulations Dr. Diana Barb!
Dr. Diana Barb Receives the 2017 Fall Faculty Enhancement Opportunity Award (FEO) The Division of Endocrinology, Diabetes & Metabolism is proud about Dr. Barb’s achievement as one of the handpicked awardees of the highly […]
Existing diabetes drug shows effectiveness against chronic liver disease
A three-year clinical trial led by University of Florida Health researcher Kenneth Cusi, M.D., found that the drug pioglitazone is safe and effective in certain patients who have nonalcoholic steatohepatitis, or […]
Diabetes Management & Good Hospital Care
Our own Dr. Kenneth Cusi, Professor and Chief of the Division of Endocrinology, Diabetes & Metabolism at the University of Florida, shares his thoughts with “Endocrine Today” on diabetes management […]
Welcome
Endocrinology is the medical specialty that studies and treats conditions of the organs that secrete hormones. Different hormones control a wide range of body functions, so an endocrinologist may be involved with a number of problems, from sexual development to osteoporosis.
The Division provides a comprehensive clinical service covering all the major fields of endocrinology on both an outpatient and an inpatient basis, including:
- Adrenal Disorders
- Pituitary Disorders
- Diabetes and Related Complications
- Diseases and Disorders of the Thyroid
- Thyroid Nodules and Tumors
- Gynecomastia
- Lipid Disorders
- Osteoporosis
- Parathyroid and Calcium Disorders
Recent News and Announcements
Dr. Kenneth Cusi – Author Insight Video for Annals of Internal Medicine
Annals of Internal Medicine Author Insight: Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized, Controlled Trial In this video, Dr. Kenneth Cusi, […]
Dr. Chris Newton Excellence in Education and Diabetes Care Award
Dear friends, It has been a month since the unexpected passing of our friend and colleague Chris Newton on May 29th, 2016. In honor of his many contributions to patients […]
DoM Excellence in Teaching Awards 2016 – Endocrinology Winners
This year the department of medicine honored a number of outstanding teachers for the 2016 DoM Excellence in Teaching Awards. Our division had two members who were honored and recognized for […]
UF Diabetes Institute
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction
June 15, 2018
This study evaluated the effects of dulaglutide vs placebo on liver and glycaemic/metabolic measurements in a population with Type 2 diabetes and in a subgroup with non-alcoholic fatty...
Dr. Matthew Gurka to Serve on NIH Study Section
May 21, 2018
Matthew Gurka, Ph.D., a professor in the Department of Health Outcomes and Biomedical Informatics (HOBI) at UF and associate director of UF’s Institute for Child Health Policy (ICHP), was selected...
UF Health receives national fellowship award to improve psychological care for children with diabetes
May 11, 2018
Psychological support is crucial for helping children with Type 1 diabetes and their families manage the disease, yet there are few child psychologists with expertise in the unique aspects of...
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
May 8, 2018
Dendritic cell (DC) immunotherapy has been effective for prevention of type 1 diabetes (T1D) in NOD mice but fails to protect if initiated after active autoimmunity. As autoreactivity expands inter-...